The India biopsy devices market size reached US$ 77.4 Million in 2022. Looking forward, the market expected to reach US$ 118.8 Million by 2028, exhibiting a growth rate (CAGR) of 7.2% during 2023-2028, according to latest research report by IMARC Group.

Biopsy devices are medical equipment used to remove inflammatory cells from the body for laboratory examination and detection of malignancy. They rely on the location of the lesion, patient history, imaging position of the mass, and intended trajectory of the needle to perform a soft-tissue biopsy of abdominal, thoracic, and other lesions. They are also used in various minimally invasive biopsy procedures, such as magnetic resonance imaging (MRI), stereotactic, and ultrasound-guided biopsies. Besides this, they find extensive applications in medical clinics, hospitals, and diagnostic centers across India.

Request Free Sample Report:

Market Trends and Drivers:

The growing prevalence of chronic oncological diseases, such as lung, breast, colorectal, and ovarian cancer, due to the increasing sedentary lifestyle of individuals represents one of the key factors driving the market in India. Apart from this, the growing demand for minimally invasive surgical procedures in cancer treatment to reduce post-operative complications is positively influencing the market in the country.

In addition, the rising exposure to ultraviolet (UV) radiations and pollutants, such as asbestos, radon, and arsenic, is propelling the growth of the market. Furthermore, increasing investments in research and development (R&D) activities by key market players to introduce technologically advanced equipment, such as vacuum-assisted guns and smart biopsy devices, are expected to bolster the growth of the market in India.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

The report has segmented the market on the basis of procedure type, product, application, guidance technique, end user and region.

By Procedure Type:

    • Surgical Biopsy
    • Needle Biopsy

By Product:

    • Biopsy Guidance Systems
    • Needle Based Biopsy Guns
    • Biopsy Needles
    • Biopsy Forceps
    • Others

Breakup by Application:

    • Breast Biopsy
    • Lung Biopsy
    • Colorectal Biopsy
    • Prostate Biopsy
    • Others

By Guidance Technique:

    • Ultrasound-guided Biopsy
    • Stereotactic-guided Biopsy
    • MRI-guided Biopsy
    • Others

By End User:

    • Hospitals and Clinics
    • Academic and Research Institutes
    • Others

By Region:

    • North India
    • West and Central India
    • South India
    • East India

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization

Ask An Analyst:-

Browse full Article with Complete Companies details:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800